Total Return chart Annexin Pharmaceuticals AB

Stocks

Market Closed - Nasdaq Stockholm 08:30:00 2026-10-30 EDT			5-day change	1st Jan Change
6.640 ^SEK	-0.90%		-15.09%	-66.46%

10-22	Annexin Enrolls Last Patient in Mid-stage Trial of Eye Disease Drug Candidate	MT
10-22	Annexin Pharmaceuticals AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.